C
The Clorox Company
CLX
$148.36
-$1.40-0.94%
C
Hold
2/4/2025Upgraded
The Clorox Company (CLX) was upgraded to C+ from C on 2/4/2025 due to a substantial increase in the valuation index, total return index and growth index. Earnings per share increased from $0.7997 to $1.54.
The Clorox Company (CLX) was upgraded to C+ from C on 2/4/2025 due to a substantial increase in the valuation index, total return index and growth index. Earnings per share increased from $0.7997 to $1.54.
C
Hold
8/15/2024Upgraded
The Clorox Company (CLX) was upgraded to C from C- on 8/15/2024 due to a large increase in the valuation index, growth index and volatility index. Earnings per share increased from -$0.4105 to $1.7269, operating cash flow increased 86.81% from $182M to $340M, and EBIT increased 12.82% from $234M to $264M.
The Clorox Company (CLX) was upgraded to C from C- on 8/15/2024 due to a large increase in the valuation index, growth index and volatility index. Earnings per share increased from -$0.4105 to $1.7269, operating cash flow increased 86.81% from $182M to $340M, and EBIT increased 12.82% from $234M to $264M.
C
Hold
2/21/2024Upgraded
The Clorox Company (CLX) was upgraded to C- from D+ on 2/21/2024 due to a major increase in the growth index, solvency index and volatility index. Operating cash flow increased 665% from $20M to $153M, EBIT increased 341.89% from $74M to $327M, and earnings per share increased from $0.17 to $0.7489.
The Clorox Company (CLX) was upgraded to C- from D+ on 2/21/2024 due to a major increase in the growth index, solvency index and volatility index. Operating cash flow increased 665% from $20M to $153M, EBIT increased 341.89% from $74M to $327M, and earnings per share increased from $0.17 to $0.7489.
D
Sell
11/3/2023Downgrade
The Clorox Company (CLX) was downgraded to D+ from C- on 11/3/2023 due to a major decline in the growth index, solvency index and volatility index. Operating cash flow declined 95.35% from $430M to $20M, earnings per share declined from $1.4136 to $0.17, and EBIT declined 70.75% from $253M to $74M.
The Clorox Company (CLX) was downgraded to D+ from C- on 11/3/2023 due to a major decline in the growth index, solvency index and volatility index. Operating cash flow declined 95.35% from $430M to $20M, earnings per share declined from $1.4136 to $0.17, and EBIT declined 70.75% from $253M to $74M.
C
Hold
8/11/2023Upgraded
The Clorox Company (CLX) was upgraded to C- from D+ on 8/11/2023 due to a noticeable increase in the growth index, solvency index and total return index. Earnings per share increased from -$1.71 to $1.4136, debt to equity declined from 900.67 to 11.92, and operating cash flow increased 26.1% from $341M to $430M.
The Clorox Company (CLX) was upgraded to C- from D+ on 8/11/2023 due to a noticeable increase in the growth index, solvency index and total return index. Earnings per share increased from -$1.71 to $1.4136, debt to equity declined from 900.67 to 11.92, and operating cash flow increased 26.1% from $341M to $430M.
D
Sell
8/1/2023Downgrade
The Clorox Company (CLX) was downgraded to D+ from C- on 8/1/2023 due to a decline in the total return index, efficiency index and volatility index.
The Clorox Company (CLX) was downgraded to D+ from C- on 8/1/2023 due to a decline in the total return index, efficiency index and volatility index.
C
Hold
7/5/2023Upgraded
The Clorox Company (CLX) was upgraded to C- from D+ on 7/5/2023 due to an increase in the volatility index and total return index.
The Clorox Company (CLX) was upgraded to C- from D+ on 7/5/2023 due to an increase in the volatility index and total return index.
D
Sell
6/20/2023Downgrade
The Clorox Company (CLX) was downgraded to D+ from C- on 6/20/2023 due to a decline in the volatility index and total return index.
The Clorox Company (CLX) was downgraded to D+ from C- on 6/20/2023 due to a decline in the volatility index and total return index.
C
Hold
5/4/2023Downgrade
The Clorox Company (CLX) was downgraded to C- from C on 5/4/2023 due to a significant decline in the valuation index, growth index and solvency index. Debt to equity increased from 8.61 to 900.67, and earnings per share declined from $0.8 to -$1.71.
The Clorox Company (CLX) was downgraded to C- from C on 5/4/2023 due to a significant decline in the valuation index, growth index and solvency index. Debt to equity increased from 8.61 to 900.67, and earnings per share declined from $0.8 to -$1.71.
C
Hold
2/6/2023Upgraded
The Clorox Company (CLX) was upgraded to C from C- on 2/6/2023 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from $0.68 to $0.8, operating cash flow increased 17.42% from $178M to $209M, and EBIT increased 10.87% from $138M to $153M.
The Clorox Company (CLX) was upgraded to C from C- on 2/6/2023 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from $0.68 to $0.8, operating cash flow increased 17.42% from $178M to $209M, and EBIT increased 10.87% from $138M to $153M.
C
Hold
11/18/2022Upgraded
The Clorox Company (CLX) was upgraded to C- from D+ on 11/18/2022 due to an increase in the total return index and volatility index.
The Clorox Company (CLX) was upgraded to C- from D+ on 11/18/2022 due to an increase in the total return index and volatility index.
D
Sell
11/3/2022Downgrade
The Clorox Company (CLX) was downgraded to D+ from C- on 11/3/2022 due to a decline in the valuation index, growth index and volatility index. Operating cash flow declined 46.87% from $335M to $178M, EBIT declined 22.91% from $179M to $138M, and earnings per share declined from $0.8196 to $0.68.
The Clorox Company (CLX) was downgraded to D+ from C- on 11/3/2022 due to a decline in the valuation index, growth index and volatility index. Operating cash flow declined 46.87% from $335M to $178M, EBIT declined 22.91% from $179M to $138M, and earnings per share declined from $0.8196 to $0.68.
C
Hold
10/25/2022Upgraded
The Clorox Company (CLX) was upgraded to C- from D+ on 10/25/2022 due to an increase in the volatility index.
The Clorox Company (CLX) was upgraded to C- from D+ on 10/25/2022 due to an increase in the volatility index.
D
Sell
10/10/2022Downgrade
The Clorox Company (CLX) was downgraded to D+ from C- on 10/10/2022 due to a noticeable decline in the growth index and total return index. Earnings per share declined from $1.21 to $0.8196, EBIT declined 19% from $221M to $179M, and total revenue declined 0.44% from $1.81B to $1.8B.
The Clorox Company (CLX) was downgraded to D+ from C- on 10/10/2022 due to a noticeable decline in the growth index and total return index. Earnings per share declined from $1.21 to $0.8196, EBIT declined 19% from $221M to $179M, and total revenue declined 0.44% from $1.81B to $1.8B.
C
Hold
5/3/2022Upgraded
The Clorox Company (CLX) was upgraded to C- from D+ on 5/3/2022 due to a large increase in the valuation index and growth index. Earnings per share increased from $0.56 to $1.21, EBIT increased 90.52% from $116M to $221M, and operating cash flow increased 26.52% from $181M to $229M.
The Clorox Company (CLX) was upgraded to C- from D+ on 5/3/2022 due to a large increase in the valuation index and growth index. Earnings per share increased from $0.56 to $1.21, EBIT increased 90.52% from $116M to $221M, and operating cash flow increased 26.52% from $181M to $229M.
D
Sell
3/21/2022Downgrade
The Clorox Company (CLX) was downgraded to D+ from C- on 3/21/2022 due to a decline in the total return index and volatility index.
The Clorox Company (CLX) was downgraded to D+ from C- on 3/21/2022 due to a decline in the total return index and volatility index.
C
Hold
2/7/2022Downgrade
The Clorox Company (CLX) was downgraded to C- from C on 2/7/2022 due to a significant decline in the valuation index, volatility index and solvency index. Debt to equity increased from 7.99 to 9.4, and the quick ratio declined from 0.34 to 0.3.
The Clorox Company (CLX) was downgraded to C- from C on 2/7/2022 due to a significant decline in the valuation index, volatility index and solvency index. Debt to equity increased from 7.99 to 9.4, and the quick ratio declined from 0.34 to 0.3.
C
Hold
6/7/2021Downgrade
The Clorox Company (CLX) was downgraded to C from C+ on 6/7/2021 due to a decline in the total return index and volatility index.
The Clorox Company (CLX) was downgraded to C from C+ on 6/7/2021 due to a decline in the total return index and volatility index.
C
Hold
5/3/2021Downgrade
The Clorox Company (CLX) was downgraded to C+ from B- on 5/3/2021 due to a significant decline in the growth index, solvency index and valuation index. Earnings per share declined from $2.03 to -$0.49, debt to equity increased from 2.4 to 3.85, and the quick ratio declined from 0.78 to 0.62.
The Clorox Company (CLX) was downgraded to C+ from B- on 5/3/2021 due to a significant decline in the growth index, solvency index and valuation index. Earnings per share declined from $2.03 to -$0.49, debt to equity increased from 2.4 to 3.85, and the quick ratio declined from 0.78 to 0.62.
B
Buy
4/7/2021Downgrade
The Clorox Company (CLX) was downgraded to B- from B on 4/7/2021 due to a major decline in the total return index, volatility index and growth index. Earnings per share declined from $3.22 to $2.03, operating cash flow declined 35.77% from $383M to $246M, and EBIT declined 23.61% from $466M to $356M.
The Clorox Company (CLX) was downgraded to B- from B on 4/7/2021 due to a major decline in the total return index, volatility index and growth index. Earnings per share declined from $3.22 to $2.03, operating cash flow declined 35.77% from $383M to $246M, and EBIT declined 23.61% from $466M to $356M.
B
Buy
9/17/2020Downgrade
The Clorox Company (CLX) was downgraded to B from B+ on 9/17/2020 due to a decline in the total return index.
The Clorox Company (CLX) was downgraded to B from B+ on 9/17/2020 due to a decline in the total return index.
B
Buy
8/20/2020Upgraded
The Clorox Company (CLX) was upgraded to B+ from B on 8/20/2020 due to a significant increase in the growth index, total return index and solvency index. Operating cash flow increased 140.26% from $308M to $740M, the quick ratio increased from 0.68 to 1.07, and earnings per share increased from $1.89 to $2.4212.
The Clorox Company (CLX) was upgraded to B+ from B on 8/20/2020 due to a significant increase in the growth index, total return index and solvency index. Operating cash flow increased 140.26% from $308M to $740M, the quick ratio increased from 0.68 to 1.07, and earnings per share increased from $1.89 to $2.4212.
B
Buy
2/11/2020Upgraded
The Clorox Company (CLX) was upgraded to B from B- on 2/11/2020 due to an increase in the growth index and volatility index.
The Clorox Company (CLX) was upgraded to B from B- on 2/11/2020 due to an increase in the growth index and volatility index.
B
Buy
11/20/2019Downgrade
The Clorox Company (CLX) was downgraded to B- from B on 11/20/2019 due to a large decline in the growth index, solvency index and total return index. Operating cash flow declined 30.33% from $389M to $271M, earnings per share declined from $1.8752 to $1.59, and EBIT declined 7.52% from $306M to $283M.
The Clorox Company (CLX) was downgraded to B- from B on 11/20/2019 due to a large decline in the growth index, solvency index and total return index. Operating cash flow declined 30.33% from $389M to $271M, earnings per share declined from $1.8752 to $1.59, and EBIT declined 7.52% from $306M to $283M.
B
Buy
7/24/2019Upgraded
The Clorox Company (CLX) was upgraded to B from B- on 7/24/2019 due to an increase in the total return index and volatility index.
The Clorox Company (CLX) was upgraded to B from B- on 7/24/2019 due to an increase in the total return index and volatility index.
B
Buy
7/9/2019Downgrade
The Clorox Company (CLX) was downgraded to B- from B on 7/9/2019 due to a decline in the total return index, solvency index and volatility index.
The Clorox Company (CLX) was downgraded to B- from B on 7/9/2019 due to a decline in the total return index, solvency index and volatility index.
B
Buy
2/15/2019Upgraded
The Clorox Company (CLX) was upgraded to B from B- on 2/15/2019 due to an increase in the growth index, solvency index and total return index. Debt to equity declined from 3.79 to 3.4.
The Clorox Company (CLX) was upgraded to B from B- on 2/15/2019 due to an increase in the growth index, solvency index and total return index. Debt to equity declined from 3.79 to 3.4.
B
Buy
1/3/2019Downgrade
The Clorox Company (CLX) was downgraded to B- from B on 1/3/2019 due to a decline in the total return index.
The Clorox Company (CLX) was downgraded to B- from B on 1/3/2019 due to a decline in the total return index.
B
Buy
11/21/2018Upgraded
The Clorox Company (CLX) was upgraded to B from B- on 11/21/2018 due to an increase in the total return index and volatility index.
The Clorox Company (CLX) was upgraded to B from B- on 11/21/2018 due to an increase in the total return index and volatility index.
B
Buy
11/6/2018Downgrade
The Clorox Company (CLX) was downgraded to B- from B on 11/6/2018 due to a substantial decline in the growth index, valuation index and dividend index. Operating cash flow declined 35.25% from $400M to $259M, EBIT declined 8.75% from $320M to $292M, and total revenue declined 7.57% from $1.69B to $1.56B.
The Clorox Company (CLX) was downgraded to B- from B on 11/6/2018 due to a substantial decline in the growth index, valuation index and dividend index. Operating cash flow declined 35.25% from $400M to $259M, EBIT declined 8.75% from $320M to $292M, and total revenue declined 7.57% from $1.69B to $1.56B.
B
Buy
8/23/2018Upgraded
The Clorox Company (CLX) was upgraded to B from B- on 8/23/2018 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 58.73% from $252M to $400M, EBIT increased 22.14% from $262M to $320M, and earnings per share increased from $1.37 to $1.6517.
The Clorox Company (CLX) was upgraded to B from B- on 8/23/2018 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 58.73% from $252M to $400M, EBIT increased 22.14% from $262M to $320M, and earnings per share increased from $1.37 to $1.6517.
B
Buy
8/6/2018Upgraded
The Clorox Company (CLX) was upgraded to B- from C+ on 8/6/2018 due to a major increase in the growth index, volatility index and dividend index. Operating cash flow increased 293.75% from $64M to $252M, total revenue increased 7.13% from $1.42B to $1.52B, and EBIT increased 6.07% from $247M to $262M.
The Clorox Company (CLX) was upgraded to B- from C+ on 8/6/2018 due to a major increase in the growth index, volatility index and dividend index. Operating cash flow increased 293.75% from $64M to $252M, total revenue increased 7.13% from $1.42B to $1.52B, and EBIT increased 6.07% from $247M to $262M.
C
Hold
4/20/2018Downgrade
The Clorox Company (CLX) was downgraded to C+ from B- on 4/20/2018 due to a decline in the volatility index and total return index.
The Clorox Company (CLX) was downgraded to C+ from B- on 4/20/2018 due to a decline in the volatility index and total return index.
B
Buy
4/19/2018Downgrade
The Clorox Company (CLX) was downgraded to B- from B on 4/19/2018 due to a decline in the volatility index and total return index.
The Clorox Company (CLX) was downgraded to B- from B on 4/19/2018 due to a decline in the volatility index and total return index.
B
Buy
3/12/2018Upgraded
The Clorox Company (CLX) was upgraded to B from B- on 3/12/2018 due to an increase in the volatility index, valuation index and dividend index.
The Clorox Company (CLX) was upgraded to B from B- on 3/12/2018 due to an increase in the volatility index, valuation index and dividend index.
B
Buy
2/5/2018Downgrade
The Clorox Company (CLX) was downgraded to B- from B on 2/5/2018 due to a noticeable decline in the volatility index, growth index and dividend index. Operating cash flow declined 75.19% from $258M to $64M, EBIT declined 17.67% from $300M to $247M, and total revenue declined 5.6% from $1.5B to $1.42B.
The Clorox Company (CLX) was downgraded to B- from B on 2/5/2018 due to a noticeable decline in the volatility index, growth index and dividend index. Operating cash flow declined 75.19% from $258M to $64M, EBIT declined 17.67% from $300M to $247M, and total revenue declined 5.6% from $1.5B to $1.42B.
B
Buy
11/3/2017Downgrade
The Clorox Company (CLX) was downgraded to B from B+ on 11/3/2017 due to a noticeable decline in the growth index and total return index. Operating cash flow declined 33.16% from $386M to $258M, total revenue declined 8.93% from $1.65B to $1.5B, and earnings per share declined from $1.5232 to $1.46.
The Clorox Company (CLX) was downgraded to B from B+ on 11/3/2017 due to a noticeable decline in the growth index and total return index. Operating cash flow declined 33.16% from $386M to $258M, total revenue declined 8.93% from $1.65B to $1.5B, and earnings per share declined from $1.5232 to $1.46.
B
Buy
8/16/2017Upgraded
The Clorox Company (CLX) was upgraded to B+ from B on 8/16/2017 due to a noticeable increase in the solvency index, growth index and total return index. Debt to equity declined from 9.44 to 6.04, earnings per share increased from $1.1324 to $1.31, and the quick ratio increased from 0.46 to 0.5.
The Clorox Company (CLX) was upgraded to B+ from B on 8/16/2017 due to a noticeable increase in the solvency index, growth index and total return index. Debt to equity declined from 9.44 to 6.04, earnings per share increased from $1.1324 to $1.31, and the quick ratio increased from 0.46 to 0.5.
B
Buy
3/16/2017Upgraded
The Clorox Company (CLX) was upgraded to B from B- on 3/16/2017 due to an increase in the total return index and volatility index.
The Clorox Company (CLX) was upgraded to B from B- on 3/16/2017 due to an increase in the total return index and volatility index.
B
Buy
12/15/2016Downgrade
The Clorox Company (CLX) was downgraded to B- from B on 12/15/2016 due to a noticeable decline in the volatility index, growth index and solvency index. Operating cash flow declined 48.64% from $331M to $170M, total revenue declined 9.81% from $1.6B to $1.44B, and debt to equity increased from 7.81 to 8.33.
The Clorox Company (CLX) was downgraded to B- from B on 12/15/2016 due to a noticeable decline in the volatility index, growth index and solvency index. Operating cash flow declined 48.64% from $331M to $170M, total revenue declined 9.81% from $1.6B to $1.44B, and debt to equity increased from 7.81 to 8.33.
B
Buy
10/31/2016Downgrade
The Clorox Company (CLX) was downgraded to B from B+ on 10/31/2016 due to a large decline in the volatility index and total return index.
The Clorox Company (CLX) was downgraded to B from B+ on 10/31/2016 due to a large decline in the volatility index and total return index.
B
Buy
9/6/2016Downgrade
The Clorox Company (CLX) was downgraded to B+ from A- on 9/6/2016 due to a major decline in the total return index, growth index and valuation index. EBIT declined 2.7% from $259M to $252M.
The Clorox Company (CLX) was downgraded to B+ from A- on 9/6/2016 due to a major decline in the total return index, growth index and valuation index. EBIT declined 2.7% from $259M to $252M.
A
Buy
5/9/2016Upgraded
The Clorox Company (CLX) was upgraded to A- from B+ on 5/9/2016 due to a large increase in the total return index.
The Clorox Company (CLX) was upgraded to A- from B+ on 5/9/2016 due to a large increase in the total return index.
B
Buy
5/5/2016Upgraded
The Clorox Company (CLX) was upgraded to B+ from B- on 5/5/2016 due to a significant increase in the growth index, solvency index and total return index. Operating cash flow increased 589.47% from $38M to $262M, debt to equity declined from 11.6 to 8.6, and earnings per share increased from $1.1248 to $1.2328.
The Clorox Company (CLX) was upgraded to B+ from B- on 5/5/2016 due to a significant increase in the growth index, solvency index and total return index. Operating cash flow increased 589.47% from $38M to $262M, debt to equity declined from 11.6 to 8.6, and earnings per share increased from $1.1248 to $1.2328.
B
Buy
4/26/2016Downgrade
The Clorox Company (CLX) was downgraded to B- from B on 4/26/2016 due to a significant decline in the growth index, total return index and dividend index. Operating cash flow declined 74.15% from $147M to $38M, earnings per share declined from $1.3124 to $1.1248, and EBIT declined 12.94% from $286M to $249M.
The Clorox Company (CLX) was downgraded to B- from B on 4/26/2016 due to a significant decline in the growth index, total return index and dividend index. Operating cash flow declined 74.15% from $147M to $38M, earnings per share declined from $1.3124 to $1.1248, and EBIT declined 12.94% from $286M to $249M.
B
Buy
8/21/2015Downgrade
The Clorox Company (CLX) was downgraded to B from B+ on 8/21/2015 due to a major decline in the solvency index, volatility index and valuation index. Debt to equity increased from 7.17 to 18.57, and the quick ratio declined from 0.7 to 0.64.
The Clorox Company (CLX) was downgraded to B from B+ on 8/21/2015 due to a major decline in the solvency index, volatility index and valuation index. Debt to equity increased from 7.17 to 18.57, and the quick ratio declined from 0.7 to 0.64.
B
Buy
6/16/2015Downgrade
The Clorox Company (CLX) was downgraded to B+ from A- on 6/16/2015 due to a noticeable decline in the total return index.
The Clorox Company (CLX) was downgraded to B+ from A- on 6/16/2015 due to a noticeable decline in the total return index.
A
Buy
5/6/2015Upgraded
The Clorox Company (CLX) was upgraded to A- from B on 5/6/2015 due to a significant increase in the growth index, volatility index and solvency index. Operating cash flow increased 541.18% from $34M to $218M, earnings per share increased from $0.9474 to $1.3037, and debt to equity declined from 9.51 to 7.17.
The Clorox Company (CLX) was upgraded to A- from B on 5/6/2015 due to a significant increase in the growth index, volatility index and solvency index. Operating cash flow increased 541.18% from $34M to $218M, earnings per share increased from $0.9474 to $1.3037, and debt to equity declined from 9.51 to 7.17.
B
Buy
11/20/2014Upgraded
The Clorox Company (CLX) was upgraded to B from B- on 11/20/2014 due to a noticeable increase in the total return index and volatility index.
The Clorox Company (CLX) was upgraded to B from B- on 11/20/2014 due to a noticeable increase in the total return index and volatility index.
B
Buy
11/5/2014Downgrade
The Clorox Company (CLX) was downgraded to B- from B on 11/5/2014 due to a significant decline in the growth index, valuation index and dividend index. Earnings per share declined from $1.2892 to $0.6813, operating cash flow declined 27.89% from $337M to $243M, and EBIT declined 13.31% from $278M to $241M.
The Clorox Company (CLX) was downgraded to B- from B on 11/5/2014 due to a significant decline in the growth index, valuation index and dividend index. Earnings per share declined from $1.2892 to $0.6813, operating cash flow declined 27.89% from $337M to $243M, and EBIT declined 13.31% from $278M to $241M.
B
Buy
8/27/2014Upgraded
The Clorox Company (CLX) was upgraded to B from B- on 8/27/2014 due to a large increase in the solvency index, total return index and dividend index. Debt to equity declined from 48.45 to 15.1, and the quick ratio increased from 0.5 to 0.53.
The Clorox Company (CLX) was upgraded to B from B- on 8/27/2014 due to a large increase in the solvency index, total return index and dividend index. Debt to equity declined from 48.45 to 15.1, and the quick ratio increased from 0.5 to 0.53.
B
Buy
5/5/2014Downgrade
The Clorox Company (CLX) was downgraded to B- from B on 5/5/2014 due to a large decline in the solvency index, volatility index and total return index. Debt to equity increased from 16.1 to 48.45, and the quick ratio declined from 0.71 to 0.5.
The Clorox Company (CLX) was downgraded to B- from B on 5/5/2014 due to a large decline in the solvency index, volatility index and total return index. Debt to equity increased from 16.1 to 48.45, and the quick ratio declined from 0.71 to 0.5.
NYSE
03/06/2025 10:40AM Eastern
Quotes delayed
